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ABSTRACT  
Leiomyoma is very commonly seen in the present times in 
Gynecological practice. The incidence is high in women in active 
reproductive age, especially in nulliparous women. These are commonly 
known as Fibroids and are composed of fibrous connective tissue. The 
majority of the small Leiomyomas and some large ones are 
asymptomatic. Fibroid which are near to endometrial cavity, can cause 
symptoms like menorrhagia, low-back pain, lower abdomen pain etc. 
Based on the clinical features this tumour can be compared with the 
Mamsajarbuda type of Arbuda, described in Ayurvedic classics. There is 
no established treatment to control the Menorrhagia induced by Fibroid 
Uterus. Hence the present study is taken up to evaluate the efficacy of 
compound formulations viz., Ashokarishtam and Lodhrasava in 
controlling excessive bleeding during menses. Study carried out on 30 
number of patients, of which, 14 (46.67%) had shown Good response, 
03 (10.00%) had shown Fair response, 06 (20.00%) had shown Poor 
response, and 07 (23.33%) cases did not show any response. On 
statistical analysis of overall parameters adopted for the study, it is 
found that the drug efficacy in controlling menorrhagia was highly 
significant (P<0.001). 
 
INTRODUCTION
Leiomyoma is the commonest of all the benign 
pelvic neoplasms. The incidence is high during active 
reproductive age of women; rare before the age of 20 
years, but are found in approximately 20% of women 
over 20 years of age and in 40% of women over the 
age of 40 years. These tumours are common in 
nulliparous or relatively infertile women.  
Leiomyoma (fibroma or fibroid) is composed of 
muscle tissue although there is a variable amount of 
fibrous connective tissue as well, especially in the 
older and large tumors. Each individual tumor is 
monoclonal in nature and arises from a somatic 
mutation in a progenitor myocyte. The tumor is 
surrounded by a pseudo capsule, consisting of 
compressed normal uterine wall. The rate of growth 
is slow and varies from individual to individual. The 
majority of the small Leiomyoma and some large ones 
are symptomless. If it is more near to endometrial 
cavity, more likely it can cause symptoms, especially 
menstrual symptoms. The characteristic symptom of 
Leiomyoma is menorrhagia, that is, an increased 
blood loss at normally spaced intervals, which is 
gradual in onset and progressive. The duration of 
flow may be normal or prolonged and the loss is 
heaviest on the second and third days1. 
The factors which are causing menorrhagia are; 
an increase in size of the endometrial cavity, 
increased vascularity of the uterus, associated with 
endometrial hyperplasia, compression of veins with 
consequent dilatation and engorgement of venous 
plexuses. Fibroid can also interfere with uterine 
contractions which are alleged to control the blood 
flow through the uterine wall1.  
Other associated symptoms are pain abdomen, 
anemia, and sometimes hypoglycemia. Continuous or 
irregular bleeding is only seen in the following 
conditions - ulceration of sub-mucous fibroid, 
polypoidal fibroid, sarcomatous change in tumor or a 
coincidental carcinoma. Fibroids can cause following 
complications like dyspepsia, frequency of urination, 
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retention of urine, edema or varicosities of legs, 
polycythemia etc. 
According to Ayurveda, benign neoplasm can be 
compared with the clinical condition ‘Arbuda’. Arbuda 
is tumour; it is of six types Vataja, Pittaja, Kaphaja, 
Siraja, Mamsaja and Medasaja2. The Arbuda which 
arises from mamsa dhatu (muscle tissue) is called 
Mamsajarbuda (tumour arising from muscular 
tissue). Since fibroid uterus is originating from 
myocyte and composed of muscle tissue, this can be 
compared with Mamsajarbuda. Main humours 
involve in the pathogenesis of Arbuda are Vata and 
Kapha3. 
Asrikdara is the condition where Rajasrava 
(menstrual flow) is excess (Asrikdeeryate yasminneti 
Asrikdara - Ca. Ci 30/201 - Cakrapani) and is 
otherwise known as Raktapradara. Vata in general 
and Apanavata in particular are the regulating factors 
of menstrual flow. If there is vitiation of Vata, that 
leads to excessive flow of rajas (menstrual blood)4. 
Arbuda when occurs in Garbhasaya that can cause 
Asrikdara due to vitiation of Vata, thereby excessive 
flow of menstrual blood.  
In clinical practice, few trials have been carried 
out on cases of fibroid uterus for the reduction of its 
size through different formulations but encouraging 
results are not found. Fibroids if asymptomatic can 
leave untreated. But, when produces symptoms like 
menorrhagia, it needs immediate treatment. Present 
trial has been taken up to evaluate Ashokarishtam and 
Lodhrasavam in Menorrhagia induced by fibroid 
uterus. 
Rationale for selection of trial drugs 
In the existing modern system of medicine, to 
control bleeding hormonal therapy, haemostatic 
drugs are available with unsure relief and side effects. 
Hence finding out alternate therapies to control 
menorrhagia induced by fibroid uterus, is highly 
essential in Gynecological point of view. 
Ashokarishta and Lodhrasava are most common 
preparations, widely prescribed in almost all sorts of 
Gynecological diseases. In Ashokarishta5, Ashoka is a 
main ingredient. Ashoka (Saraca asoca Roxb) is the 
drug of choice in diseases that occur from menarche 
to menopause. It is having simulative effect on 
ovarian tissue and on endometrium. It is astringent in 
taste; especially bark is having strong astringent and 
sedative effect. It acts directly on the muscular fibres 
of the uterus. In the classics it’s actions are described 
as Grahi (binding/constipating), Raktasangraha 
(hemostatic), Vedanasthapana (analgesic); useful in 
clinical conditions like Kashtartava (dysmenorrhoea), 
Svetapradara (leucorrhoea), Raktarshas (bleeding 
hemorrhoids), Raktatisara (bloody diarrhea) etc and 
reduce Garbhasaya sithilata6&7. 
In Lodhrasava, Lodhra (Symplocos racemosa 
Roxb.) is the main ingredient. Lodhra is the best 
astringent drug and well prescribed for Gynecological 
disorders, since Caraka Samhita period8. Lodhra is 
having bitter and astringent taste, coolant in nature. 
It is containing alkaloids namely loturine, loturidine 
and colloturine, which may be to be responsible for 
astringent activity of lodhra. On pharmacological 
study, a crystalline fraction from the bark was found 
to reduce the frequency and intensity of the 
contractions in vitro of both pregnant and non-
pregnant uteri of some animals. A glycoside isolated 
from the stem bark, named 3-monoglucofuranoside 
of 7-o-methyl leucopelargonidin is highly astringent 
and is reported to be responsible for medicinal 
properties of the bark8.  
Many number of clinical studies have been 
carried out by different investigators on different 
indications with these drugs like Raktapradara 
(menorrhagia), Svetapradara (leucorrhoea), 
Strivandhyatva (female infertility) etc. But very 
scattered references of studies on Fibroid induced 
Menorrhagia are available. Hence the present study is 
taken up with these two well known preparations to 
evaluate clinically to see their efficacy in fibroid 
induced Menorrhagia cases. 
MATERIALS AND METHODS 
Aims: 1).To evaluate the efficacy of trial drugs in 
controlling bleeding in fibroid induced Menorrhagia 
2). To evaluate the efficacy of trial drugs in the 
reduction of fibroid size. 
Sample size and Study design 
Design of study – Open trial 
Sample size – 30 
Trial drug schedule 
Dose: Ashokarishtam – 10 ml BD 
Lodhrasavam – 10 ml BD both drugs are to be taken 
30 minutes after food along with equal amount of 
water. 
Duration of therapy: 3 months 
Follow-up: 30th day, 60th day and 90th day. 
Methods: Total 33 cases were recruited for the study, 
of which 03 patients were dropped out due to 
irregular follow-up. All the subjects of trial were 
drawn from OPD of A. L. Research Centre for 
Ayurveda, VHS and incorporated according to the 
criteria of selection. Assessment of clinical 
parameters was done on initial day, 30th day, 60th day 
and 90th day. USG abdomen had done before and after 
treatment. Laboratory parameters were also assessed 
on initial day and final day of trial. 
Source of trial drugs: IMPCOPS, Chennai. 
Criteria of Inclusion 
1. Woman in active reproductive age i.e., between 
20 – 45 years. 
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2. History of heavy or prolonged bleeding with or 
with out clots for minimum 3 cycles. 
3. Single or multiple fibroids in uterus confirmed 
on USG. 
Criteria of Exclusion 
1. Woman below the age of 20 and above 45 years. 
2. History of heavy bleeding during menses due to 
DUB. 
3. Menorrhagia due to adenomyoma, ovarian 
cysts, sarcoma, carcinoma or chorio carcinoma 
of the uterus. 
4. Woman with below 7gm/dl haemoglobin. 
5. Menorrhagia due to Pelvic inflammatory disease 
or local lesions of cervix /vagina. 
Criteria of Withdrawal 
1. Not showing any improvement 
2. Development of any side effects 
3. Irregular intake of drug and irregular follow-
up 
Criteria of Assessment of Results 
1. Good Response: Complete normalcy of 
menstrual flow, and complete relief from 
associative symptoms like pain abdomen, low 
back pain and cases with >75 -100% relief. 
2. Fair Response: Normalcy of menstrual flow, 
but no relief in associated clinical symptoms and 
percentage of relief between 51 -74%. 
3. Poor Response: Reduction in heavy menstrual 
flow and no relief in associated symptoms and 
percentage of relief between 25% -50%. 
4. No Response: No reduction in heavy menstrual 
flow and associated symptoms and percentage 
of relief less than 25% are considered under this 
group. 
PARAMETERS ADOPTED FOR ASSESSMENT: 
Parameter                                                      Gradation                                                        
1. Duration of menstrual flow  
Severe – excessive bleeding p/v for >7 
days 
 
20 
Moderate – excessive bleeding p/v for 
>5 days 
 
10 
Mild - excessive bleeding p/v for >3 
days 
 
05 
2. Amount of Menstrual flow  
Severe – Soakage of >4 diapers in day & 
> 2 in night 
 
20 
Moderate – Soakage of >3 diapers in 
day & > 1 in night 
 
10 
Mild - Soakage of >2 diapers in day & > 
1 in night 
 
05 
3. Pain abdomen  
Severe pain abdomen, needs analgesics 
/anti-spasmodics  
 
20 
Moderate – Pain abdomen, forced to 
take rest  
 
10 
Mild – Dull colic pain in abdomen, 
patient is able to carry out routine 
 
05 
works 
4. Low back pain  
Severe – excruciating low back pain, 
needs analgesics  
 
20 
Moderate – intense low back pain, force 
the patient to take rest 
 
10 
Mild – dull pain and patient is able to 
carry out routine works   
 
05 
5. Hemoglobin  
Hemoglobin between 7-8 gms/dl 20 
Hemoglobin between 8-9 gms/dl 10 
Hemoglobin between 9-10 gms/dl 05 
OBSERVATIONS 
Demographic data 
Table I: Showing the incidence of age 
Age in years No of cases Percentage 
20 -25  00 00.00 
25-30 04 13.33 
30 -35 06 20.00 
35 - 40 11 36.67 
40 -45 09 30.00 
Total 30 100.00 
Table II: Showing the incidence of Parity 
Type Number Percentage 
Nullipara 07 23.33 
Primipara 05 16.67 
Multipara 18 60.00 
Total 30 100.00 
Table III: Showing the Incidence of Prakriti 
  Vata Pitta Kapha Vata 
Pitta 
Pitta 
Kapha 
Vata 
Kapha 
Sama Total 
No - - - 11 09 10 - 30 
% - - - 36.67 30.00 33.33 - 100.00 
Table IV: Incidence of Occupation 
  House 
wife 
Desk 
work 
Field 
work 
Field work 
intellectual 
Physical 
Labour 
Total 
No 16 07 00 03 04 30 
% 53.33 23.33 00.00 10.00 13.34 100.00 
CLINICAL DATA 
Table V: Changes in duration of menstrual flow 
before & after treatment 
Duration of 
menstrual 
flow 
Before treatment After treatment 
No Percentage No Percentage 
> 7 days 08 26.66 02 06.67 
5-7 days 11 36.67 05 16.66 
3-5 days 11 36.67 06 20.00 
< 3 days 00 00.00 17 56.67 
Total 30 100.00 30 100.00 
 
 
Table VI: Changes in amount of menstrual flow 
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Amount of 
menstrual 
flow 
Before treatment After 
treatment 
No Percentage No Percentage 
Severe 19 63.33 01 03.33 
Moderate 11 36.67 14 46.67 
Mild 00 00.00 07 23.33 
Normal 00 00.00 08 26.67 
Total 30 100.00 30 100.00 
Table VII: Changes in pain abdomen during 
menstruation before & after treatment 
Pain 
Abdomen 
Before treatment After treatment 
No Percentage No Percentage 
Severe 01 03.33 01 03.33 
Moderate 23 76.67 05 16.67 
Mild 02 06.67 12 40.00 
No pain 04 13.33 12 40.00 
Total 30 100.00 30 100.00 
Table VIII: Changes in Fibroid on USG before and 
after treatment 
Fibroid size Before 
treatment 
After treatment 
Number % Number % 
Seedling 04 13.33 04 13.34 Seedling 
2-3 cm 10 33.33 10 33.33 2-3 cm 
3-4cm 08 26.67 06 20.00 3-4cm 
>4 cm 08 26.67 10 33.33 >4 cm 
Total 30 100.00 30 100.00 Total 
Table IX: Results of the study  
  GR FR PR NR Total 
Number 14 03 06 07 30 
Percentage 46.67 10.00 20.00 23.33 100.00 
Table X: Statistical analysis of efficacy of trial 
drug on overall parameters 
 Before 
treatment 
After 
treatment 
Difference 
Mean 54 23.16 30.63 
SD 8.16 11.87 12.67 
SE 1.51 2.20 2.35 
-t   13.11 
P   <0.001 
DISCUSSION 
Fibroids are common phenomenon during 
active reproductive phase. In some cases these are 
asymptomatic, but when these are present as 
submucous fibroids, they can cause Menorrhagia. 
Hence the present study is taken up to evaluate the 
efficacy of Ashokarishta and Lodhrasava, two 
Ayurvedic herbal liquids in the management of 
fibroid (s) induced Menorrhagia. Study carried out in 
30 cases, of which, 14 (46.67%) cases had shown 
Good response, 03 (10.00%) cases had shown Fair 
response, 06 (20.00%) cases had shown Poor 
Response, and 07 (23.33%) cases did not show any 
response. 
Out of 30 total cases, majority of the women 
i.e., 11(36.67%) were seen under 35-40 years age 
group and 09 (30.00) under 40-45 years of age group. 
All the women were observed under Dvanda 
prakrities, and equally distributed under Vatapitta, 
Vatakapha, Pittakapha. Most of the women were 
multiparous 18 (60.00) women, and are House wives 
16 (53.33%). 
Analysis of two import parameters, duration 
of menstrual flow and amount of menstrual flow 
shown that; Before treatment, more than 7 days 
duration was seen in 26.66% of women, 5-7 days 
excessive flow was seen in 36.67% of women, and 3-5 
days excessive flow was seen in 36.67% women. After 
treatment more than 7 days flow was seen only in 
06.67% and 5-7 days excessive flow was seen in 
16.66%, 3-5 days excessive flow was seen in 20.00% 
of women.  
Before treatment; amount of flow was severe 
in 63.33% and moderate in 36.67% and after 
treatment the flow was observed severe in 03.33% 
and moderate in 46.67%, mild in 23.33% and 
bleeding was normal in 26.67%.  
Another important symptom i.e., pain 
abdomen was severe in 03.33%, moderate in 76.67% 
and mild in 06.67% and pain was not there in 
13.33%, before treatment. After treatment pain was 
severe in 03.33%, moderate in 16.67%, mild in 
40.00% and 40.00% become pain free.  
Pelvic USG carried out before and after 
treatment, before treatment to confirm the diagnosis 
and after treatment to see the change in size. 
However, there are no significant changes observed 
in the size of the fibroids. 
On statistical analysis of overall parameters 
adopted for the study, it is found that the drug 
efficacy in controlling Menorrhagia was highly 
significant (P<0.001). Out of 30 completed cases 14 
(46.67%) had shown Good response, 03 (10.00%) 
had shown Fair response, 06 (20.00%) had shown 
Poor response, and 07 (23.33%) cases did not show 
any response.  
Modus Operandi of trial drugs 
In Ashokarishta, Ashoka (Saraca indica) is the 
main ingredient, having Kashaya, Tikta rasa. Bark is 
highly astringent and uterine sedative may be due to 
the presence of hemotoxilin. It is having Rakta 
sangraha, Vedanasthapana properties. It is containing 
phenolic-glycoside and non-phenolic glycoside. Pure 
phenolic glycoside is non-toxic in nature. It is having 
pharmacological activities like astringent, anti-tumor, 
anti-fungal, antifertility, spasmodic action in uterine 
affections etc.  
 In Lodhrasava, Lodhra (Symplocos racemosa) 
is the main ingredient. It is having Tikta, Kashaya 
rasa, Sita virya. It is also highly effective astringent, 
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and this astringent action can be attributed to an 
alkaloid present in Lodhra bark called loturodine. 
 These two drugs might have acted in synergy 
in controlling fibroid induced menorrhagia. 
Dysmenorrhoea was also relieved effectively after 
treatment in Good number of patients; this may be 
due to uterine sedative action of Ashoka.  
CONCLUSIONS 
1. Leomyomas are the commonest among all the 
benign pelvic neoplasms.  
2. These can induce menstrual symptoms like 
menorrhagia, dysmenorrhoea etc. 
3. Menorrhagia can be compared with ‘Asrikdara’ 
based on cardinal feature of excessive bleeding 
per vaginum during menstruation, as per 
Ayurveda. 
4. Fibroid induced menorrhagia can be compared 
with Mamsajarbudaja Asrikdara, since tumour 
from soft muscle origin is called Mamsajarbuda. 
5. Hormonal and all other haemostatic medicines 
are not effective in controlling excessive 
menstrual flow. 
6. Ashokarishta and Lodhrasava are age old 
classical preparations found effective in 
controlling excessive uterine and vaginal 
discharges. 
7. The present study is taken up to evaluate the 
haemostatic effect of both the drugs in fibroid 
induced menorrhagia. 
8. From this study total 56.67% of patients got 
benefited. 
9. On statistical analysis these drugs are found 
highly significant (P<0.001).  
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